Hairy Cell Leukemia (HCL) Terminated Phase 1 Trials for PLX8394 (DB16038)

Also known as: Hairy-cell Leukemia / Hairy cell leukaemia / Hairy Cell Leukemia / Leukemia, Hairy Cell / Leukemic reticuloendotheliosis / Hairy cell leukemia (disorder) / Hairy cell leukemia (morphologic abnormality) / Hairy cell leukemia with failed remission / Leukemic reticuloendotheliosis -RETIRED- / Leukaemic reticuloendotheliosis / Leukemic reticuloendotheliosis NOS (disorder) / Leukemic reticuloendotheliosis of unspecified sites (disorder) / [M]Leukaemic reticuloendotheliosis

IndicationStatusPhase
DBCOND0046776 (Hairy Cell Leukemia (HCL))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02012231Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Treatment